| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
|
30,451 |
28,831 |
$2.73M |
| 99213 |
|
18,640 |
17,606 |
$1.16M |
| 93306 |
|
4,210 |
4,200 |
$720K |
| 76816 |
|
13,011 |
11,404 |
$688K |
| 93880 |
|
2,377 |
2,375 |
$386K |
| 76818 |
|
7,394 |
3,690 |
$352K |
| 99204 |
|
2,496 |
2,493 |
$337K |
| 99232 |
|
5,583 |
2,847 |
$306K |
| 99203 |
|
3,117 |
3,113 |
$291K |
| 93229 |
|
469 |
466 |
$271K |
| 76817 |
|
6,561 |
5,848 |
$247K |
| 76819 |
|
5,289 |
4,590 |
$239K |
| 76811 |
|
1,870 |
1,858 |
$204K |
| 99223 |
Prolong inpt eval add15 m |
1,188 |
1,172 |
$162K |
| 93000 |
|
10,933 |
10,739 |
$152K |
| 43239 |
|
1,335 |
1,330 |
$141K |
| 76820 |
|
5,837 |
3,500 |
$132K |
| 78452 |
|
354 |
353 |
$130K |
| 76815 |
|
3,973 |
2,694 |
$122K |
| 99391 |
|
1,322 |
1,305 |
$109K |
| 76821 |
|
2,823 |
1,672 |
$96K |
| 76801 |
|
1,662 |
1,560 |
$95K |
| 99233 |
Prolong inpt eval add15 m |
1,102 |
459 |
$86K |
| 93015 |
|
1,261 |
1,257 |
$77K |
| 99392 |
|
769 |
769 |
$74K |
| 99479 |
|
616 |
246 |
$61K |
| 99480 |
|
498 |
241 |
$49K |
| 76813 |
|
753 |
752 |
$47K |
| A9502 |
Technetium tc-99m tetrofosmin, diagnostic, per study dose |
283 |
283 |
$44K |
| 99215 |
Prolong outpt/office vis |
334 |
324 |
$41K |
| 90677 |
|
262 |
261 |
$40K |
| G2066 |
Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and technician review, technical support and distribution of results |
447 |
441 |
$39K |
| 85025 |
|
5,527 |
5,131 |
$36K |
| 76830 |
|
396 |
385 |
$35K |
| 93268 |
|
156 |
155 |
$29K |
| 99205 |
Prolong outpt/office vis |
147 |
147 |
$26K |
| 76805 |
|
424 |
420 |
$25K |
| 90471 |
|
1,702 |
1,680 |
$24K |
| 45380 |
|
119 |
119 |
$23K |
| 99469 |
|
63 |
24 |
$23K |
| 99212 |
|
473 |
457 |
$22K |
| 93298 |
|
538 |
516 |
$16K |
| 93224 |
|
183 |
181 |
$14K |
| 90472 |
|
920 |
918 |
$14K |
| 76942 |
|
209 |
199 |
$13K |
| 76857 |
|
304 |
282 |
$13K |
| 93244 |
|
616 |
611 |
$12K |
| 36415 |
|
8,179 |
7,868 |
$11K |
| 73562 |
|
293 |
285 |
$11K |
| 99244 |
|
76 |
76 |
$10K |
| 99231 |
|
292 |
160 |
$10K |
| 45378 |
|
52 |
52 |
$10K |
| 99464 |
|
134 |
134 |
$9K |
| 20610 |
|
174 |
162 |
$9K |
| 99222 |
|
88 |
88 |
$9K |
| 96365 |
|
120 |
114 |
$8K |
| 90697 |
|
121 |
119 |
$8K |
| 93228 |
|
465 |
462 |
$8K |
| 20553 |
|
216 |
194 |
$7K |
| 81003 |
|
3,549 |
3,303 |
$6K |
| 93458 |
|
27 |
27 |
$6K |
| 0002A |
|
162 |
162 |
$6K |
| 0001A |
|
137 |
137 |
$5K |
| 93242 |
|
337 |
333 |
$3K |
| 0012A |
|
75 |
75 |
$3K |
| J1756 |
Injection, iron sucrose, 1 mg |
51 |
50 |
$3K |
| 90682 |
|
50 |
50 |
$3K |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
558 |
538 |
$3K |
| 92587 |
|
159 |
152 |
$2K |
| 0011A |
|
64 |
64 |
$2K |
| 73610 |
|
70 |
68 |
$2K |
| 99443 |
|
20 |
17 |
$2K |
| 90460 |
|
123 |
121 |
$2K |
| J2785 |
Injection, regadenoson, 0.1 mg |
12 |
12 |
$2K |
| 94729 |
|
32 |
32 |
$1K |
| 93923 |
|
14 |
14 |
$1K |
| 94060 |
|
31 |
31 |
$1K |
| 99239 |
|
14 |
14 |
$1K |
| 94727 |
|
32 |
32 |
$1K |
| 99381 |
|
13 |
13 |
$1K |
| G0108 |
Diabetes outpatient self-management training services, individual, per 30 minutes |
15 |
12 |
$1K |
| 76825 |
|
14 |
12 |
$1K |
| 95251 |
|
31 |
31 |
$1K |
| 99395 |
|
12 |
12 |
$1K |
| 73100 |
|
34 |
26 |
$937.68 |
| 75574 |
|
12 |
12 |
$897.41 |
| 99406 |
|
84 |
82 |
$895.48 |
| G2211 |
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) |
83 |
82 |
$881.81 |
| 81025 |
|
124 |
121 |
$727.91 |
| 73564 |
|
12 |
12 |
$698.25 |
| 20551 |
|
34 |
25 |
$670.54 |
| 73630 |
|
15 |
13 |
$650.76 |
| 83036 |
|
80 |
80 |
$613.04 |
| 73502 |
|
12 |
12 |
$513.40 |
| 81002 |
|
198 |
172 |
$469.15 |
| 73130 |
|
13 |
12 |
$433.76 |
| 76827 |
|
14 |
12 |
$344.84 |
| 81000 |
|
104 |
102 |
$336.83 |
| 90656 |
|
15 |
15 |
$315.67 |
| 3074F |
|
3,670 |
3,535 |
$300.00 |
| 72170 |
|
12 |
12 |
$266.92 |
| 73620 |
|
12 |
12 |
$244.27 |
| 82948 |
|
91 |
90 |
$244.11 |
| 93016 |
|
12 |
12 |
$228.60 |
| 3078F |
|
2,246 |
2,170 |
$220.00 |
| 94016 |
|
13 |
13 |
$211.26 |
| J1030 |
Injection, methylprednisolone acetate, 40 mg |
12 |
12 |
$190.42 |
| 3008F |
|
21,273 |
20,170 |
$149.38 |
| 1159F |
|
21,705 |
20,344 |
$140.49 |
| 51798 |
|
12 |
12 |
$110.13 |
| 90680 |
|
388 |
387 |
$103.03 |
| 3079F |
|
151 |
149 |
$80.00 |
| 90674 |
|
29 |
29 |
$64.74 |
| 92551 |
|
12 |
12 |
$33.19 |
| 1160F |
|
21,793 |
20,415 |
$20.74 |
| 2000F |
|
16,437 |
15,618 |
$20.74 |
| J3490 |
Unclassified drugs |
153 |
144 |
$15.64 |
| 91300 |
|
255 |
247 |
$13.23 |
| 1101F |
|
5,744 |
5,445 |
$9.90 |
| 90461 |
|
12 |
12 |
$8.82 |
| 1125F |
|
181 |
168 |
$3.30 |
| 90633 |
|
24 |
24 |
$0.00 |
| 90670 |
|
351 |
349 |
$0.00 |
| G1004 |
Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program |
63 |
63 |
$0.00 |
| 3077F |
|
13 |
12 |
$0.00 |
| 36416 |
|
39 |
39 |
$0.00 |
| 90698 |
|
306 |
304 |
$0.00 |
| 1126F |
|
727 |
686 |
$0.00 |
| 90686 |
|
54 |
54 |
$0.00 |
| 90744 |
|
13 |
12 |
$0.00 |
| 91301 |
|
94 |
94 |
$0.00 |